76 related articles for article (PubMed ID: 1258514)
1. [Influence of propafenon on hemodynamics of the left ventricle and atrioventricular conduction with special reference to the WPW syndrome].
Probst P; Pachinger O
Z Kardiol; 1976 Mar; 65(3):213-24. PubMed ID: 1258514
[TBL] [Abstract][Full Text] [Related]
2. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
3. [Electrophysiologic effects of penticainide in patients with supraventricular tachycardia].
Kühlkamp V; Mewis C; Mayer F; Seipel L
Z Kardiol; 1990 Oct; 79(10):725-31. PubMed ID: 2087860
[TBL] [Abstract][Full Text] [Related]
4. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
Seipel L; Breithardt G; Both A
Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
[TBL] [Abstract][Full Text] [Related]
5. [Electrophysiologic effects of propafenone in patients with sinus node dysfunction].
Alboni P; Filippi L; Pirani R; Preziosi S; Paparella N
G Ital Cardiol; 1984 Apr; 14(4):297-303. PubMed ID: 6735023
[TBL] [Abstract][Full Text] [Related]
6. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
Manz M; Kuhl AJ; Lüderitz B
Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
[TBL] [Abstract][Full Text] [Related]
7. [Effect of oral propafenon on accessory pathways of atrioventricular conduction].
Lacroix H; Frank R; Tonet JL; Fontaine G; Wajman A; Squeir S; Grosgogeat Y
Arch Mal Coeur Vaiss; 1985 Apr; 78(4):622-7. PubMed ID: 2860884
[TBL] [Abstract][Full Text] [Related]
8. [Electrophysiologic characterization of propafenone in man].
Masini G; Dianda R; Masini M
G Ital Cardiol; 1984 Apr; 14(4):293-6. PubMed ID: 6735022
[TBL] [Abstract][Full Text] [Related]
9. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
Manz M; Beermann J; Gerckens U; Lüderitz B
Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
[TBL] [Abstract][Full Text] [Related]
10. [Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome].
Touboul P; Porte J; Huerta F; Delahaye JP
Arch Mal Coeur Vaiss; 1976 Aug; 69(8):855-63. PubMed ID: 823923
[TBL] [Abstract][Full Text] [Related]
11. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
Kühlkamp V; Ickrath O; Haasis R; Seipel L
Z Kardiol; 1988 Aug; 77(8):527-33. PubMed ID: 3176596
[TBL] [Abstract][Full Text] [Related]
12. [Reciprocating tachycardia and anterograde conduction by a nodoventricular pathway].
Motté G; Grolleau R; Rebuffat G; Sebag C; Davy JM; Slama R
Arch Mal Coeur Vaiss; 1983 Feb; 76(2):155-66. PubMed ID: 6407423
[TBL] [Abstract][Full Text] [Related]
13. Accessory pathway reciprocating tachycardia.
Obel OA; Camm AJ
Eur Heart J; 1998 May; 19 Suppl E():E13-24, E50-1. PubMed ID: 9717020
[TBL] [Abstract][Full Text] [Related]
14. [Electrophysiologic effects of lorcainide (R 15889) in man].
Touboul P; Atallah G; Kirkorian G
Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1333-40. PubMed ID: 6797372
[TBL] [Abstract][Full Text] [Related]
15. [Electrophysiologic effects of propafenone in subjects with pre-existing excito-conduction disorders].
Rizzo A; Fiorilli R; Lisanti P
G Ital Cardiol; 1984 May; 14(5):377-8. PubMed ID: 6468820
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the antiarrhythmic agent propaphenone on cardiac conduction. clinical studies using bundle of his electrography].
Beck OA; Witt E; Hochrein H
Z Kardiol; 1975 Feb; 64(2):179-87. PubMed ID: 238345
[TBL] [Abstract][Full Text] [Related]
17. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
Kim YH; Leitch JW; Klein GJ; Yee R; Leather RA
Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the effect of Melixetin (Kö 1173) on AV-conduction time and sinus pulse automation in persons with healthy hearts and in patients with disorders of the impulse-conduction system].
Lang KF; Just H; Limbourg P
Z Kardiol; 1975 May; 64(5):389-95. PubMed ID: 1189534
[TBL] [Abstract][Full Text] [Related]
19. [Electrophysiological analysis of atrioventricular and intraventricular conduction in bi- and tri-fascicular blocks].
Ducceschi V; Sarubbi B; Mayer MS; De Divitiis M; Briglia N; Scialdone A; Santangelo L; Iacono A
Minerva Cardioangiol; 1997 Mar; 45(3):87-93. PubMed ID: 9213825
[TBL] [Abstract][Full Text] [Related]
20. [Hemodynamic and electrophysiologic effects of the new calcium antagonist Ro 11-1781 (author's transl)].
Bödeker K; Bischoff KO; Menken U; Hager W
Z Kardiol; 1980 Nov; 69(11):790-6. PubMed ID: 7467662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
